Drägerwerk 9M 2026 EBIT rises 45% to EUR 111.8 million

By Public Technologies
  • Dräger’s nine-month 2026 EBIT rose 45% year-over-year to EUR 111.8 million, including EUR 27.9 million in customs refunds.
  • Third-quarter EBIT fell 15% year-over-year to EUR 48 million, while net sales increased to EUR 850.8 million.
  • For the first nine months, net sales rose year-over-year to EUR 2.45 billion.
  • Nine-month order intake increased year-over-year to EUR 2.67 billion, with Germany the largest growth driver.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Drägerwerk AG & Co. KGaA published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2424128_en) on October 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.